Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Change in Accured Expenses: 2011-2024

Historic Change in Accured Expenses for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $2.9 million.

  • Mimedx Group's Change in Accured Expenses fell 39.95% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 250.32%. This contributed to the annual value of $2.9 million for FY2024, which is 58.34% up from last year.
  • According to the latest figures from FY2024, Mimedx Group's Change in Accured Expenses is $2.9 million, which was up 58.34% from $1.8 million recorded in FY2023.
  • Mimedx Group's 5-year Change in Accured Expenses high stood at $2.9 million for FY2024, and its period low was -$20.5 million during FY2021.
  • Its 3-year average for Change in Accured Expenses is $2.4 million, with a median of $2.4 million in 2022.
  • Per our database at Business Quant, Mimedx Group's Change in Accured Expenses slumped by 733.55% in 2021 and then spiked by 111.54% in 2022.
  • Yearly analysis of 5 years shows Mimedx Group's Change in Accured Expenses stood at -$2.5 million in 2020, then tumbled by 733.55% to -$20.5 million in 2021, then surged by 111.54% to $2.4 million in 2022, then fell by 22.70% to $1.8 million in 2023, then skyrocketed by 58.34% to $2.9 million in 2024.